Qingzhu G. Jia

P.R. China
Xinqiao, 400037, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

Glycolytic reprogramming in cancer: tumour cell metabolism, immune modulation, and therapeutic opportunities.

Glycolytic reprogramming in cancer: tumour cell metabolism, immune modulation, and therapeutic opportunities.

Journal: Journal of translational medicine

Published: January 21, 2026

Publisher Correction: SLC2A1+ tumour-associated macrophages spatially control CD8+ T cell function and drive resistance to immunotherapy in non-small-cell lung cancer.

Publisher Correction: SLC2A1+ tumour-associated macrophages spatially control CD8+ T cell function and drive resistance to immunotherapy in non-small-cell lung cancer.

Journal: Nature cell biology

Published: January 19, 2026

Tumor-derived DNA drives cancer-associated anemia by promoting reticulocyte clearance.

Tumor-derived DNA drives cancer-associated anemia by promoting reticulocyte clearance.

Journal: Signal transduction and targeted therapy

Published: July 23, 2025

SLC2A1+ tumour-associated macrophages spatially control CD8+ T cell function and drive resistance to immunotherapy in non-small-cell lung cancer.

SLC2A1+ tumour-associated macrophages spatially control CD8+ T cell function and drive resistance to immunotherapy in non-small-cell lung cancer.

Journal: Nature cell biology

Published: June 02, 2025

Multi-institutional development and validation of habitat imaging for predicting outcomes of first-line immunotherapy in advanced non-small cell lung cancer.

Multi-institutional development and validation of habitat imaging for predicting outcomes of first-line immunotherapy in advanced non-small cell lung cancer.

Journal: Translational lung cancer research

Published: May 09, 2025

DNASE1L3-expressing dendritic cells promote CD8+ T cell function and anti-PD-(L)1 therapy efficacy by degrading neutrophil extracellular traps.

DNASE1L3-expressing dendritic cells promote CD8+ T cell function and anti-PD-(L)1 therapy efficacy by degrading neutrophil extracellular traps.

Journal: Cancer cell

Published: November 12, 2024

Data science-centric design, discovery, and evaluation of novel synthetically accessible polyimides with desired dielectric constants.

Data science-centric design, discovery, and evaluation of novel synthetically accessible polyimides with desired dielectric constants.

Journal: Chemical science

Published: July 26, 2024

Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy through osteopontin-producing osteoclasts.

Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy through osteopontin-producing osteoclasts.

Journal: Cancer cell

Published: June 30, 2024

Baseline tumour vessel perfusion as a non-invasive predictive biomarker for immune checkpoint therapy in non-small-cell lung cancer.

Baseline tumour vessel perfusion as a non-invasive predictive biomarker for immune checkpoint therapy in non-small-cell lung cancer.

Journal: BMJ oncology

Published: May 15, 2024

Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative review.

Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative review.

Journal: Translational lung cancer research

Published: February 04, 2024

IFN-α/β/IFN-γ/IL-15 pathways identify GBP1-expressing tumors with an immune-responsive phenotype.

IFN-α/β/IFN-γ/IL-15 pathways identify GBP1-expressing tumors with an immune-responsive phenotype.

Journal: Clinical and experimental medicine

Published: January 24, 2024

NK cell transfer overcomes resistance to PD-(L)1 therapy in aged mice.

NK cell transfer overcomes resistance to PD-(L)1 therapy in aged mice.

Journal: Experimental hematology & oncology

Published: December 19, 2023

Showing 1-12 of 68

Last Updated: 09/26/2026